Bank Julius Baer & Co. Ltd, Zurich Cyclerion Therapeutics, Inc. Transaction History

Bank Julius Baer & Co. Ltd, Zurich

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 23, 2021	SELL	$2.18 - $4.29 $26,160 - $51,480	-12,000 Closed	0 $0
Q1 2021 May 10, 2021	SELL	$2.69 - $5.12 $16,070 - $30,586	-5,974 Reduced 33.24%	12,000 $33,000
Q4 2020 Feb 24, 2021	SELL	$2.25 - $7.12 $58 - $185	-26 Reduced 0.14%	17,974 $55,000
Q4 2020 Feb 12, 2021	BUY	$2.25 - $7.12 $9,085 - $28,750	4,038 Added 28.92%	18,000 $55,000
Q1 2020 May 13, 2020	BUY	$2.46 - $5.84 $34,346 - $81,538	13,962 New	13,962 $37,000

293K

Ticker CYCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,479,800
Market Cap $139M
Description
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.